Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia - Concepedia

Concepedia

Publication | Open Access

Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia

DOI Full Paper Access

22

Citations

47

References

2020

Year

Christopher A. Eide, Stephen E. Kurtz, Andy Kaempf, Nicola Long, Anupriya Agarwal, Cristina E. Tognon, Motomi Mori, Brian Druker, Bill H. Chang, Alexey V. Danilov,

Hematological MalignancyOncologySimultaneous Kinase InhibitionAcute Myeloid LeukemiaMedicineHematologyImmunologyMixed-phenotype Acute LeukemiaMalignant Blood DisorderPharmacotherapyAnti-cancer AgentImmunotherapyPharmacologyBcl2 InhibitionMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1